Navigation Links
Progen Receives Nasdaq Notice Regarding Board Composition
Date:4/22/2009

BRISBANE, Calif., April 22 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA; the "Company") has received a letter dated 17th April 2009 from the Nasdaq Stock Market, notifying the Company that it no longer meets the independent director, audit and compensation committee requirements for continued listing on The Nasdaq Stock Market under Rules 5605(b)(1)1, 5605(c)(2)(A)2 and 5605(d)(2)3 (the "Rules"), and requiring that the receipt of the letter be announced.

The letter also requires the Company to provide the Nasdaq, by 4 May 2009, with the Company's specific plan and timetable to achieve compliance with the rules. The Company will provide Nasdaq with a plan for meeting the above-referenced Nasdaq listing rules within that timeframe.

This letter only applies to the Company's shares trading on The Nasdaq Capital Market and not the Company's shares trading on the Australian Securities Exchange, the Company's home exchange. Approximately 5.03 million of Progen's total issued capital of 60.55 million shares (8.3% of total issued capital) trade on The Nasdaq Capital Market.

This situation developed as a result of the removal from the Board of the four independent directors Mal Eutick, John Lee, Patrick Burns and Robert Williamson during the 27th of March 2009 General Meeting of Progen shareholders, as reported by the Company at the time. Before the end of the Company's current fiscal year, which ends on the 30th of June 2009, Progen intends to expand the board with independent directors and appoint an independent Chairman.

About Progen

Progen Pharmaceuticals Limited is a biotechnology company committed to the discovery, development and commercialisation of small molecule pharmaceuticals primarily for the treatment of cancer. Progen has built a
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth
2. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
3. ProGenTech Limited Appoints Executive Management Team
4. ProGenTech Completes $21 Million Series C Financing
5. Radioactive progenies of thoron can be measured accurately, thanks to the PTB
6. Neural progenitor cells as reservoirs for HIV in the brain
7. Progen Investor Teleconference Dial In Details
8. Elusive pancreatic progenitor cells found in mice
9. Imaging neural progenitor cells in the living human brain
10. Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
11. Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... New York, NY (PRWEB) September 19, 2014 ... steam over the five years to 2014. Industry operators ... first time during the period, as well as establish ... growth is due in large part to its novelty; ... 2005. Nevertheless, in that time, industry operators have been ...
(Date:9/19/2014)... 19, 2014 Follow us ... surgical techniques, and immunosuppressant drugs to prevent rejection, ... several chronic diseases related to the heart, kidneys, ... tissue transplantation have phenomenally revolutionized the survival rate ... today represents a pivotal medical intervention for thousands ...
(Date:9/19/2014)... well in infertile land, and bear many beans that ... because most legumes have a symbiotic relationship with bacteria, ... and then supply the host plant with ammonia as ... called nodules in their roots. However, if too many ... growth of the plants, because the energy cost of ...
(Date:9/19/2014)... Lifeinsure.biz has released a new blog post presenting 5 ... medical examinations. , Life insurance riders can drive ... more advantageous. Clients can read the newly released blog ... a no medical exam life insurance policy. , ... purchase, however it is more expensive. Life insurance rates ...
(Date:9/19/2014)... September 19, 2014 Ticket Down ... for his 2014 concert tour. Concertgoers can add ... business, there are a handful of artists that are considered ... in Saginaw, MichIgan, Wonder has been a force in the ... in the music business, he has released 23 studio albums, ...
Breaking Medicine News(10 mins):Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Long-distance communication from leaves to roots 2Health News:No Medical Exam Life Insurance - Lifeinsure.biz Presents 5 Important Riders! 2Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 2Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 3
... devastating brain injury that has wiped out many of ... other peoples feelings and intentions, according to a joint ... Centre for Aging and the Brain, and York Universitys ... published in the Nov. 23, 2007 issue of Science, ...
... sleepiness, experts say, , , THURSDAY, Nov. 22 (HealthDay News) ... Thanksgiving feast aren,t rare, and experts say a number ... , It may have to do with the traditional ... a chemical known to promote sleepiness, said Donna Arand, ...
... future treatment of breast cancer have been identified by a ... the online open access journal Breast Cancer Research may focus ... , A team led by Professor Mitch Dowsett, Head of ... London and Surrey, together with colleagues from the USA, Switzerland ...
... CHICAGO, Nov. 21 The Female Health Company,(Amex: ... The Wall Street,Analyst Forum 18th Annual Analyst Conference on ... York City (on 43rd Street between 5th and,6th). The ... will,present at the conference at 11:50 a.m. Eastern Time ...
... mean more ozone, and more strain on hearts, researchers ... temperatures and high ozone levels work together to boost ... , They believe that global warming -- which brings ... the number of people who die of cardiovascular events. ...
... PICK: Pregnant women pass on the effects of smoking ... effects on fetal development. A new study in mice ... Toronto, Canada, now adds the possibility that smoking before ... of female offspring to the long list of possible ...
Cached Medicine News:Health News:People with rare type of memory loss still sensitive to others, study shows 2Health News:People with rare type of memory loss still sensitive to others, study shows 3Health News:There's More Than Turkey Behind Holiday Yawns 2Health News:Found in translation: Prioritizing research questions in breast cancer 2Health News:The Female Health Company to Present at Wall Street Analyst Forum Wednesday, November 28, 2007 2Health News:Global Warming May Trigger Rise in Heart Deaths 2Health News:Global Warming May Trigger Rise in Heart Deaths 3Health News:JCI table of contents: Nov. 21, 2007 2Health News:JCI table of contents: Nov. 21, 2007 3Health News:JCI table of contents: Nov. 21, 2007 4Health News:JCI table of contents: Nov. 21, 2007 5Health News:JCI table of contents: Nov. 21, 2007 6Health News:JCI table of contents: Nov. 21, 2007 7Health News:JCI table of contents: Nov. 21, 2007 8Health News:JCI table of contents: Nov. 21, 2007 9Health News:JCI table of contents: Nov. 21, 2007 10
(Date:9/19/2014)... EASTON, Mass. , Sept. 19, 2014 /PRNewswire/ ... "Company") today announced it has received and approved ... Barozyme HT48 instruments and has begun to manufacture ... the first instrument will be ready for shipment ... be built and released at a rate of ...
(Date:9/19/2014)... 19, 2014 Aufgrund der ... äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die ... verfügbar unter pharmaserialisation.com , zeigt die Serialisierungsanforderungen ... in Kraft treten. Für international tätige ... um das "ob", sondern darum, "wann" sie die ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
Target illumination for day and night testing. Glare luminance distance. The Optec 3500 remote control offers flexible positioning during test administration. Each vision tester includes 12 tests sli...
... The CSV- lOOOHGT instrument provides standardized glare testing. ... Vectorvision test faces for the evaluation of glare ... is precisely calibrated to simulate two on-coming halogen ... feet. The glare level can be adjusted to ...
Ruler S/Steel....
Medicine Products: